Clinical Trial Update: Randomized Study of Obicetrapib as an Adjunct to Statin Therapy [Phase 2]

View source ↗

Summary

Phase 2 randomized study of Obicetrapib added to statin therapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypercholesterolemia

Drugs mentioned

• Obicetrapib (obicetrapib)

Snippet

Sponsor: NewAmsterdam Pharma | Conditions: Dyslipidemias, High Cholesterol | Phase 2 | Status: COMPLETED | Results posted: 2024-06-11